Invention Grant
US07825238B2 Antiviral methods employing double esters of 2′, 3′-dideoxy-3′-fluoroguanosine
失效
采用2'，3'-二脱氧-3'-氟鸟嘌呤双酯的抗病毒方法
- Patent Title: Antiviral methods employing double esters of 2′, 3′-dideoxy-3′-fluoroguanosine
- Patent Title (中): 采用2'，3'-二脱氧-3'-氟鸟嘌呤双酯的抗病毒方法
-
Application No.: US11335429Application Date: 2006-01-18
-
Publication No.: US07825238B2Publication Date: 2010-11-02
- Inventor: Xiao-Xiong Zhou , Horst Wahling
- Applicant: Xiao-Xiong Zhou , Horst Wahling
- Applicant Address: SE Huddinge
- Assignee: Medivir AB
- Current Assignee: Medivir AB
- Current Assignee Address: SE Huddinge
- Agency: Birch, Stewart, Kolasch and Birch, LLP
- Priority: SE9800452 19980213; SE9800469 19980216; SE9801216 19980403; ZA98/7267 19980813; WOPCT/SE98/01467 19980814; SE9803438 19981007
- Main IPC: C07C229/00
- IPC: C07C229/00 ; C07H19/20
Abstract:
A method for treatment of HBV and HIV infections comprising administering the compound or salt of formula Ig
Public/Granted literature
- US20060122383A1 Antiviral methods employing double esters of 2', 3'-dideoxy-3'-fluoroguanosine Public/Granted day:2006-06-08
Information query
